KIAA1609 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.136800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.342800E-01
Normal-vs-Stage2
1.922430E-01
Normal-vs-Stage3
4.174600E-01
Normal-vs-Stage4
2.378400E-01
Stage1-vs-Stage2
5.619200E-01
Stage1-vs-Stage3
8.963000E-01
Stage1-vs-Stage4
6.756600E-01
Stage2-vs-Stage3
5.371400E-01
Stage2-vs-Stage4
9.962000E-01
Stage3-vs-Stage4
6.334400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.225000E-01
Normal-vs-AfricanAmerican
2.371200E-01
Normal-vs-Asian
3.541600E-01
Caucasian-vs-AfricanAmerican
8.056200E-01
Caucasian-vs-Asian
4.504200E-01
AfricanAmerican-vs-Asian
4.734000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.081200E-01
Normal-vs-Female
2.327600E-01
Male-vs-Female
5.929000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.309400E-01
Normal-vs-Age(41-60Yrs)
1.156640E-01
Normal-vs-Age(61-80Yrs)
2.791800E-01
Normal-vs-Age(81-100Yrs)
2.611200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.332400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.736600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.689000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.002500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.111400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.493000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.512000E-01
Normal-vs-Daily Drinker
2.677600E-01
Normal-vs-Weekly Drinker
3.663400E-01
Normal-vs-Occasional Drinker
7.787700E-02
Normal-vs-Social Drinker
3.056800E-01
Non Drinker-vs-Daily Drinker
9.125000E-01
Non Drinker-vs-Weekly Drinker
4.909000E-01
Non Drinker-vs-Occasional Drinker
4.636400E-02
Non Drinker-vs-Social Drinker
8.119400E-01
Daily Drinker-vs-Weekly Drinker
3.942000E-01
Daily Drinker-vs-Occasional Drinker
5.775500E-02
Daily Drinker-vs-Social Drinker
8.815400E-01
Weekly Drinker-vs-Occasional Drinker
1.525800E-02
Weekly Drinker-vs-Social Drinker
3.818400E-01
Occasional Drinker-vs-Social Drinker
1.380220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.186620E-01
Normal-vs-Grade 2
1.143830E-02
Normal-vs-Grade 3
2.395800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.179100E-04
Grade 1-vs-Grade 3
1.3548999999724E-06
Grade 1-vs-Grade 4
1.186620E-01
Grade 2-vs-Grade 3
5.420700E-03
Grade 2-vs-Grade 4
1.143830E-02
Grade 3-vs-Grade 4
2.395800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.550600E-01
Normal-vs-NonDiabetic
2.089000E-01
Diabetic-vs-NonDiabetic
4.017600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.561700E-02
Normal-vs-NoPancreatitis
2.339400E-01
Pancreatitis-vs-NoPancreatitis
4.210200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.382000E-01
Normal-vs-N1
1.986830E-01
N0-vs-N1
5.975600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.833420E-04
Normal-vs-TP53-NonMutant
5.701800E-01
TP53-Mutant-vs-TP53-NonMutant
4.03859945485863E-10
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
